Midazolam (Versed)

What it treats

Midazolam is approved by the U.S. Food and Drug Administration for:

• Procedural sedation and preoperative anxiety.
• Anesthesia induction.
• Status epilepticus, prolonged seizures (Nayzilam nasal spray; buccal formulations).
• ICU sedation for mechanically ventilated patients.

It isn't approved or used for chronic outpatient anxiety, panic disorder, or insomnia. That role is filled by longer-acting benzodiazepines or, more often, by non-benzodiazepine options.

How it works

Midazolam is a benzodiazepine. It strengthens the effect of GABA, the brain's main calming chemical messenger. By boosting GABA's signal, it quiets nerve activity fast. Given intravenously, it takes hold in a minute or two. That speed is what makes it useful in the operating room and the emergency department, and why it's not something you keep in a pill bottle.

Receptor mechanism (detail)

Midazolam is a positive allosteric modulator at the GABA-A receptor. It doesn't switch the receptor on by itself. It makes GABA's own signal stronger. Midazolam is highly water-soluble in its formulation but becomes very lipid-soluble at physiological pH, so it crosses the blood-brain barrier quickly. Half-life is roughly 1.5 to 2.5 hours in healthy adults, longer in critical illness or hepatic impairment.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual. These are all clinician-administered doses.

• Procedural sedation: IV 0.5 to 2 mg, repeat as needed, titrated to effect.
• Preoperative anxiolysis (adults): IM 0.07 to 0.08 mg per kg about an hour before procedure.
• Status epilepticus (Nayzilam nasal spray): 5 mg into one nostril, may repeat once after 10 minutes if seizure continues.
• Pediatric preop: oral syrup 0.25 to 0.5 mg per kg (rarely used now with alternative options).
• ICU sedation: continuous IV infusion, titrated.

Safety monitoring

• Respiratory depression and apnea, especially with IV administration or with concurrent opioids.
• Continuous monitoring during procedural use. Pulse oximetry, blood pressure, cardiac rhythm.
• Reversal agent available. Flumazenil can reverse midazolam sedation, though it carries its own risks (seizures in benzodiazepine-dependent patients).
• Boxed warning for procedural sedation. Only clinicians trained in airway management and rescue should administer IV midazolam.
• Older adults and critically ill patients need lower doses and prolonged monitoring.
• Do not combine with opioids without a clear plan and monitoring (FDA boxed warning).

What to expect

Common side effects

• Drowsiness and sedation, expected.
• Amnesia for the procedure, often expected.
• Headache and mild nausea afterward.
• Injection site pain or irritation.
• Hiccups.
• Mild drop in blood pressure or heart rate.

Serious side effects and warnings

Boxed warning: respiratory depression and death. IV midazolam has been associated with respiratory depression and respiratory arrest, especially when used for sedation in non-critical care settings without appropriate monitoring. It should only be used with continuous cardiorespiratory monitoring and immediate availability of resuscitation equipment.

Boxed warning: combining with opioids. Midazolam plus opioids can cause profound sedation, slowed breathing, coma, and death.

• Airway compromise. Older adults, critically ill patients, and children are at higher risk. Slower titration and lower doses are used.
• Paradoxical reactions. Agitation, restlessness, or combativeness instead of sedation, more common in children and older adults.
• Prolonged sedation with organ dysfunction, especially liver disease.
• Injection site reactions.

Sexual side effects

Midazolam is used in acute and short-term settings, so sexual side effects aren't a typical concern the way they are with daily medications.

Weight, appetite, and sleep

Not applicable to routine short-term use. In prolonged ICU sedation, sleep architecture is disrupted (that's true for most sedatives).

Starting and dosing basics

This section is general background. Midazolam is administered by a clinician in a monitored setting, not taken at home. Dose depends on the procedure, age, other medications, and how a person responds.

Missed doses and interactions

There isn't a "missed dose" concept for procedural midazolam. The interactions that matter most are opioids and other CNS depressants (dangerous combination), CYP3A4 inhibitors (raise midazolam levels significantly), and grapefruit juice (raises oral midazolam levels).

Stopping and tapering

A single procedural dose doesn't require tapering. Prolonged ICU use, over days to weeks, can produce tolerance and withdrawal, which is managed by the ICU team as sedation is weaned.

Pregnancy and breastfeeding

Midazolam crosses the placenta. Its use in pregnancy is generally limited to procedural situations where it's clearly needed. Anyone pregnant or breastfeeding should have this reviewed by the treating clinician.

Cost and generic availability

Midazolam is generic and inexpensive as a hospital medication. The Nayzilam nasal spray (approved for prolonged seizure clusters) is branded and more expensive; some insurance covers it for that indication.

Common questions

Why didn't I remember much after the procedure? Midazolam commonly causes anterograde amnesia. You form fewer new memories while it's active. That's a feature for procedures, not a bug.

Can I take midazolam at home for anxiety? No. It's not prescribed as an outpatient anxiety medication. Its speed of onset and short duration make it wrong for that purpose, and its risks in unmonitored settings are too high.

How is Nayzilam different? Nayzilam is midazolam nasal spray, kept at home by patients with a specific type of seizure disorder for use when a prolonged seizure cluster starts. It has to be prescribed and demonstrated with a caregiver, and it's not a general anti-anxiety medication.

How is it different from lorazepam or diazepam? Midazolam is much shorter acting and much more lipid-soluble, so it hits fast and clears fast. Lorazepam and diazepam are used for outpatient anxiety, procedures, and status epilepticus; midazolam mostly for acute and procedural use.

Questions to ask your prescriber

• What is midazolam being used for in my care?
• How long will the effects last, and when am I safe to drive again?
• Which of my medications interact with it?
• If I have a history of sleep apnea or COPD, does that change how it's used?
• If a nasal spray is being prescribed for seizures, when and how should I use it?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes and current as of June 8, 2026.

• U.S. Food and Drug Administration. Midazolam injection and Nayzilam nasal spray prescribing information.
• MedlinePlus, U.S. National Library of Medicine. Midazolam.
• American Society of Anesthesiologists. Practice Guidelines for Moderate Procedural Sedation and Analgesia.
• Neurocritical Care Society. Guidelines for the Evaluation and Management of Status Epilepticus.
• American Geriatrics Society. Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023).